1
|
Kolmar L, Autour A, Ma X, Vergier B, Eduati F, Merten CA. Technological and computational advances driving high-throughput oncology. Trends Cell Biol 2022; 32:947-961. [PMID: 35577671 DOI: 10.1016/j.tcb.2022.04.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2022] [Revised: 04/11/2022] [Accepted: 04/20/2022] [Indexed: 01/21/2023]
Abstract
Engineering and computational advances have opened many new avenues in cancer research, particularly when being exploited in interdisciplinary approaches. For example, the combination of microfluidics, novel sequencing technologies, and computational analyses has been crucial to enable single-cell assays, giving a detailed picture of tumor heterogeneity for the very first time. In a similar way, these 'tech' disciplines have been elementary for generating large data sets in multidimensional cancer 'omics' approaches, cell-cell interaction screens, 3D tumor models, and tissue level analyses. In this review we summarize the most important technology and computational developments that have been or will be instrumental for transitioning classical cancer research to a large data-driven, high-throughput, high-content discipline across all biological scales.
Collapse
Affiliation(s)
- Leonie Kolmar
- Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - Alexis Autour
- Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
| | - Xiaoli Ma
- Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - Blandine Vergier
- Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - Federica Eduati
- Department of Biomedical Engineering, Eindhoven University of Technology, 5612 AZ Eindhoven, The Netherlands; Institute for Complex Molecular Systems, Eindhoven University of Technology, 5612 AZ Eindhoven, The Netherlands.
| | - Christoph A Merten
- Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
| |
Collapse
|
2
|
Gros A, Gerber Z, Menguy S, Ducharme O, Bresson-Bepoldin L, Vergier B, Beylot-Barry M, Pham-Ledard A, Merlio JP. Transcriptomic landscape of primary cutaneous diffuse large B-cell lymphoma, leg type reveals novel therapeutic clues. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00567-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
3
|
Pham-Ledard A, Menguy S, Prochazkova-Carlotti M, Azzi-Martin L, Ferte T, Bresson-Bepoldin L, Vergier B, Merlio JP, Beylot-Barry M. Proliferative tumor infiltrating lymphocytes within microenvironment impact prognosis in cutaneous B-cell lymphomas. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00560-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
4
|
Darmon-Novello M, Adam J, Lamant L, Battistella M, Ortonne N, Balme B, de la Fouchardière A, Chaltiel L, Gerard E, Franchet C, Vergier B. Harmonization of PD-L1 immunohistochemistry and mRNA expression scoring in metastatic melanoma: a multicenter analysis. Histopathology 2022; 80:1091-1101. [PMID: 35322452 DOI: 10.1111/his.14651] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Revised: 02/21/2022] [Accepted: 03/21/2022] [Indexed: 11/29/2022]
Abstract
AIMS This multicenter study sought to harmonize programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) data and melanoma scoring. To provide a reference for PD-L1 expression independent of the IHC protocol, PD-L1 mRNA expression was determined then compared to IHC. METHODS Standardized PD-L1 assays (22C3, 28-8, SP142, and SP263) and laboratory-developed tests (QR1 and 22C3) were evaluated on three IHC platforms using a training set of 7 cases. mRNA expression was determined via RNAscope (CD274/PD-L1 probe) and analyzed by image analysis. PD-L1 IHC findings were scored by seven blinded pathologists using the tumor proportion score (TPS), combined positive score (CPS), and MELscore. This method was validated by three blinded pathologists on 40 metastatic melanomas. RESULTS Concordances among various antibody/platforms were high across antibodies (ICC > 0.80 for CPS), except for SP142. Two levels of immunostaining intensities were observed: high (QR1 and SP263) and low (28-8, 22C3, and SP142). Reproducibilities across pathologists were higher for QR1 and SP263 (ICC ≥ 0.87 and ≥ 0.85 for TPS and CPS, respectively). QR1, SP263, and 28-8 showed the highest concordance with mRNA expression (ICC ≥ 0.81 for CPS). We developed a standardized method for PD-L1 immunodetection and scoring, tested on 40 metastatic melanomas. Concordances among antibodies were excellent for all criteria, and concordances among pathologists were better for the MELscore than for other scores. CONCLUSION Harmonization of PD-L1 staining and scoring in melanomas with good concordance is achievable using the PD-L1 IHC protocols applied to other cancers; this reproducible approach can simplify daily practice.
Collapse
Affiliation(s)
- M Darmon-Novello
- Department of Pathology, Bordeaux University Hospital and INSERM U1053, Bordeaux, France
| | - J Adam
- Department of Pathology, Gustave Roussy Institute, Paris, France
| | - L Lamant
- Department of Pathology, Oncopole University Hospital Toulouse, France
| | - M Battistella
- Department of Pathology, Hôpital Saint-Louis, AP-HP, Université de Paris, INSERM U976 HIPI, Paris, France
| | - N Ortonne
- Department of Pathology, University Hospital Henri Mondor, Creteil-, Paris, France
| | - B Balme
- Department of Pathology, University Hospital Lyon, France
| | | | - L Chaltiel
- Department of Biostatistics, Institut Claudius Regaud IUCT-O, Toulouse, France
| | - E Gerard
- Department of Dermatology, Bordeaux University Hospital, Bordeaux, France
| | - C Franchet
- Department of Pathology, Oncopole University Hospital Toulouse, France
| | - B Vergier
- Department of Pathology, Bordeaux University Hospital and INSERM U1053, Bordeaux, France
| |
Collapse
|
5
|
Cluet D, Vergier B, Levy NP, Dehau L, Thurman A, Amri I, Spichty M. Titration of apparent in-cellula affinities of protein-protein interactions. Chembiochem 2021; 23:e202100640. [PMID: 34932835 DOI: 10.1002/cbic.202100640] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2021] [Revised: 12/21/2021] [Indexed: 11/07/2022]
Abstract
A genetic assay permits simultaneous quantification of two interacting proteins and their bound fraction at the single-cell level using flow cytometry. Apparent in-cellula affinities of protein-protein interactions can be extracted from the acquired data through a titration-like analysis. The applicability of this approach is demonstrated on a diverse set of interactions with proteins from different families and organisms and with in-vitro dissociation constants ranging from picomolar to micromolar.
Collapse
Affiliation(s)
- David Cluet
- Laboratoire de Biologie et de Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364, Lyon cedex 07, France
| | - Blandine Vergier
- Laboratoire de Biologie et de Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364, Lyon cedex 07, France
| | - Nicolas-Pierre Levy
- Laboratoire de Biologie et de Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364, Lyon cedex 07, France
| | - Lucie Dehau
- Laboratoire de Biologie et de Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364, Lyon cedex 07, France
| | - Alexandre Thurman
- Laboratoire de Biologie et de Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364, Lyon cedex 07, France
| | - Ikram Amri
- Laboratoire de Biologie et de Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364, Lyon cedex 07, France
| | - Martin Spichty
- Laboratoire d'Innovation Moléculaire et Applications, Université de Strasbourg -, Centre National de la Recherche Scientifique, Université de Haute-Alsace, 3 bis rue Alfred Werner, 68057, Mulhouse Cedex, France
| |
Collapse
|
6
|
Bourlond F, Battistella M, Amici JM, Dousset L, Vergier B, Beylot-Barry M, Cribier B. Clinicopathologic analysis of trichoblastoma and comparison with nodular basal cell carcinoma. Ann Dermatol Venereol 2021; 148:177-182. [PMID: 34176642 DOI: 10.1016/j.annder.2021.03.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 12/15/2020] [Accepted: 03/18/2021] [Indexed: 10/21/2022]
Abstract
BACKGROUND Trichoblastoma (TB) is an uncommon benign follicular tumour for which clinical data is limited since most reports originate from pathology studies. OBJECTIVE To describe the clinical aspects of TB. METHODS This is an ancillary study of a prospective multicentre cohort of 2710 clinically suspected basal cell carcinoma (BCC), including 935 nodular BCCs. Sixty-two cases were TB: they were analysed and compared to 935 nodular BCCs. RESULTS TB mostly occurred in females (61% vs. 43% for BCC, P<0.01) of mean age 63 years. They were located on the head and neck, mainly on the nose and forehead, in 87% of cases. The mean size was 8.1mm, 77% were<10mm (55% of BCCs, P<0.001), 8% were ulcerated (vs. 21% of BCCs, P<0.02), and 47% persisted for more than 1 year (34% of BCCs, P<0.05). Most cases had a clinical presentation similar to nodular BCC, except for 5 small, flat, white papules and 1 anfractuous plaque. LIMITATIONS Cases originated from a series of tumours clinically suspected as BCCs. DISCUSSION Some 2.6% of tumours clinically diagnosed as BCC are in fact TB. TB occurs on the head, are more frequent in women, and are smaller and of longer duration than BCC. In most cases, clinical diagnosis on clinical grounds is difficult.
Collapse
Affiliation(s)
- F Bourlond
- Dermatology Clinic, Strasbourg University Hospitals, 1, place de l'Hôpital, 67091 Strasbourg, France.
| | - M Battistella
- Pathology Department, Saint-Louis Hospital AP-HP, Paris University, INSERM U976, 1, avenue Claude-Vellefaux, 75010 Paris, France
| | - J-M Amici
- Dermatology Department, Bordeaux University Hospital, Saint-André Hospital, 1, rue Jean-Burguet, 33000 Bordeaux, France
| | - L Dousset
- Dermatology Department, Bordeaux University Hospital, Saint-André Hospital, 1, rue Jean-Burguet, 33000 Bordeaux, France
| | - B Vergier
- Anatomic Pathology Department, Bordeaux University Hospital, Haut-Lévêque Hospital, avenue du Haut-Lévêque, 33604 Pessac, France
| | - M Beylot-Barry
- Dermatology Department, Bordeaux University Hospital, Saint-André Hospital, 1, rue Jean-Burguet, 33000 Bordeaux, France; Inserm U1053, 146, rue Léo-Saignat, 33000 Bordeaux, France
| | - B Cribier
- Dermatology Clinic, Strasbourg University Hospitals, 1, place de l'Hôpital, 67091 Strasbourg, France
| |
Collapse
|
7
|
Skayem C, Beylot-Barry M, de Masson A, Dereure O, Ram-Wolff C, Bagot M, Vergier B, Battistella M, Ortonne N, Ingen-Housz-Oro S. Lymph node and visceral progression without erythroderma or blood worsening in erythrodermic cutaneous T-cell lymphoma: nine cases. Br J Dermatol 2021; 185:1061-1063. [PMID: 34128541 DOI: 10.1111/bjd.20580] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2021] [Revised: 06/08/2021] [Accepted: 06/13/2021] [Indexed: 12/01/2022]
Affiliation(s)
- C Skayem
- Department of Dermatology, AP-HP, Henri Mondor Hospital, Créteil, France
| | - M Beylot-Barry
- Department of Dermatology, Bordeaux University Hospital, Bordeaux, France.,INSERM U1053, Bordeaux Research in Translational Oncology (BaRITOn), Cutaneous Lymphoma Oncogenesis Team, Bordeaux University, Bordeaux, France.,French Cutaneous Lymphomas Study Group (GFELC), Paris, France
| | - A de Masson
- French Cutaneous Lymphomas Study Group (GFELC), Paris, France.,Department of Dermatology, AP-HP, Saint-Louis Hospital, Université de Paris, INSERM U976, Paris, France
| | - O Dereure
- French Cutaneous Lymphomas Study Group (GFELC), Paris, France.,Department of Dermatology, University of Montpellier and INSERM U1058 Pathogenesis and Control of Chronic Infections, Montpellier, France
| | - C Ram-Wolff
- French Cutaneous Lymphomas Study Group (GFELC), Paris, France.,Department of Dermatology, AP-HP, Saint-Louis Hospital, Université de Paris, INSERM U976, Paris, France
| | - M Bagot
- French Cutaneous Lymphomas Study Group (GFELC), Paris, France.,Department of Dermatology, AP-HP, Saint-Louis Hospital, Université de Paris, INSERM U976, Paris, France
| | - B Vergier
- INSERM U1053, Bordeaux Research in Translational Oncology (BaRITOn), Cutaneous Lymphoma Oncogenesis Team, Bordeaux University, Bordeaux, France.,French Cutaneous Lymphomas Study Group (GFELC), Paris, France.,Department of Pathology, Bordeaux University Hospital, Bordeaux, France
| | - M Battistella
- French Cutaneous Lymphomas Study Group (GFELC), Paris, France.,Department of Pathology, AP-HP, Saint-Louis Hospital, Université de Paris, INSERM U976, Paris, France
| | - N Ortonne
- French Cutaneous Lymphomas Study Group (GFELC), Paris, France.,Department of Pathology, AP-HP, Henri Mondor Hospital, Créteil, France.,Paris Est Créteil University (UPEC) and IMRB, INSERM U955 Team Ortonne (NFL), Créteil, France
| | - S Ingen-Housz-Oro
- Department of Dermatology, AP-HP, Henri Mondor Hospital, Créteil, France.,French Cutaneous Lymphomas Study Group (GFELC), Paris, France.,University Paris Est Créteil EpiDermE, Créteil, France
| |
Collapse
|
8
|
Bergqvist C, Beylot-Barry M, Ram-Wolff C, Vergier B, Bagot M, Battistella M, Dalle S, Balme B, Merlio JP, Durupt F, Le Corre Y, Bonnet N, Le Bozec P, Skowron F, Vivard-Wallee I, Dereure O, Brunet-Possenti F, Ingen-Housz-Oro S, Ortonne N. Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group. Clin Exp Dermatol 2021; 46:1441-1451. [PMID: 33987864 DOI: 10.1111/ced.14730] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/10/2021] [Indexed: 11/30/2022]
Abstract
BACKGROUND Lymphomatoid papulosis (LyP) type D (LyP D) and type E (LyP E) have recently been described in small series of cases or isolated case reports. AIM To further describe the clinical and histological features of LyP D and E based on a retrospective multicentre study. METHODS The clinical and histopathological features of 29 patients with an initial diagnosis of LyP D or LyP E were retrospectively assessed using standardized forms. RESULTS After exclusion of 5 cases, 24 patients (14 LyP D, 10 LyP E) were enrolled in the study. The median follow-up was 2.5 years (range 1 month to 13 years). LyP D was characterized by multiple recurrent self-regressing small papules that developed central erosion or necrosis, whereas LyP E presented as papulonodular lesions that rapidly evolved into necrotic eschar-like lesions > 10 mm in size. Epidermal changes were more frequent in LyP D, whereas dermal infiltrates were deeper in LyP E. Anaplastic cytology was rare and the DUSP22 rearrangement was never observed. Two patients (8%) had an associated cutaneous lymphoma. CONCLUSION LyP D and E have distinct clinical findings and may be associated with other cutaneous lymphomas.
Collapse
Affiliation(s)
- C Bergqvist
- Department of, Dermatology, AP-HP, Hôpital Henri Mondor, Créteil, France
| | - M Beylot-Barry
- Department of, Dermatology, Bordeaux University Hospital, Bordeaux, France.,Cutaneous Lymphoma Oncogenesis Team, INSERM U1053 Bordeaux Research in Translational Oncology (BaRITOn), Bordeaux University, Bordeaux, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - C Ram-Wolff
- French Cutaneous Lymphomas Study Group, Paris, France.,Department of, Dermatology, AP-HP, Hôpital Saint-Louis, Université de Paris, Paris, France
| | - B Vergier
- Department of, Pathology, Bordeaux University Hospital, Bordeaux, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - M Bagot
- French Cutaneous Lymphomas Study Group, Paris, France.,Department of, Dermatology, AP-HP, Hôpital Saint-Louis, Université de Paris, Paris, France
| | - M Battistella
- French Cutaneous Lymphomas Study Group, Paris, France.,Department of, Pathology, AP-HP, Hôpital Saint-Louis, Université de Paris, Paris, France
| | - S Dalle
- French Cutaneous Lymphomas Study Group, Paris, France.,Department of, Dermatology, University Hospital of Lyon-Sud, Lyon, France
| | - B Balme
- French Cutaneous Lymphomas Study Group, Paris, France.,Department of, Dermatology, University Hospital of Lyon-Sud, Lyon, France.,Department of, Pathology, University Hospital of Lyon-Sud, Lyon, France
| | - J P Merlio
- Cutaneous Lymphoma Oncogenesis Team, INSERM U1053 Bordeaux Research in Translational Oncology (BaRITOn), Bordeaux University, Bordeaux, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - F Durupt
- Department of Dermatology, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France
| | - Y Le Corre
- French Cutaneous Lymphomas Study Group, Paris, France.,Department of Dermatology, CHU Angers, Angers, France
| | - N Bonnet
- French Cutaneous Lymphomas Study Group, Paris, France.,Department of Dermatology, Hôpitaux de Marseille, Marseille, France
| | - P Le Bozec
- Department of Dermatology, AP-HP, Hôpital Beaujon, Clichy, France
| | - F Skowron
- French Cutaneous Lymphomas Study Group, Paris, France.,Department of Dermatology, Centre Hospitalier de Valence, Valence, France
| | | | - O Dereure
- French Cutaneous Lymphomas Study Group, Paris, France.,Department of Dermatology, CHU de Montpellier, Montpellier, France
| | - F Brunet-Possenti
- French Cutaneous Lymphomas Study Group, Paris, France.,Department of Dermatology, AP-HP, Hôpital Bichat, Paris, France
| | - S Ingen-Housz-Oro
- Department of, Dermatology, AP-HP, Hôpital Henri Mondor, Créteil, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - N Ortonne
- Department of, Pathology, AP-HP, Hôpital Henri Mondor, Créteil, France.,French Cutaneous Lymphomas Study Group, Paris, France.,Paris Est Creteil University (UPEC) and IMRB, INSERM U955 Team Ortonne (NFL), Créteil, France
| |
Collapse
|
9
|
Menguy S, Mansour Y, Augereau O, Ortonne N, Balme B, Battistella M, Lamant L, Beltzung F, Szablewski V, Gaulard P, Bagot M, Beylot-Barry M, Vergier B. Impact des algorithmes du Groupe Français d’Étude des Lymphomes Cutanés sur le diagnostic anatomopathologique des lymphoproliférations cutanées. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
10
|
Khammari A, Dinulescu M, Nguyen JM, Cassecuel J, Maillard H, Le Duff F, Machet L, Beylot-Barry M, Legoupil D, Wierzbicka-Hainaut E, Bedane C, Leccia MT, Debarbieux S, Meyer N, Monestier S, Bens G, Denis M, Vourch M, Bossard C, Vergier B, Dréno B. L’efficacité de l’imiquimod dans la prise en charge du mélanome de Dubreuilh in situ (lentigo malin). Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
11
|
Dobos G, de Masson A, Ram-Wolff C, Beylot-Barry M, Pham-Ledard A, Ortonne N, Oro S, Battistella M, d’Incan M, Rouanet J, Franck F, Vignon-Pennamen MD, Franck N, Carlotti A, Boulinguez S, Lamant L, Petrella T, Dalac S, Joly P, Courville P, Rivet J, Dereur O, Amatore F, Taix S, Grange F, Durlach A, Quéreux G, Josselin N, Moulonguet I, Mortier L, Dubois R, Maubec E, Laroche L, Michel L, Templier I, Barete S, Nardin C, Augereau O, Vergier B, Bagot M. Changements dans l’épidémiologie des lymphomes cutanés primitifs en France : une analyse de 8593 patients du registre du Groupe Français d’Etude des Lymphomes Cutanés (GFELC). Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
12
|
Dobos G, de Masson A, Ram-Wolff C, Beylot-Barry M, Pham-Ledard A, Ortonne N, Ingen-Housz-Oro S, Battistella M, d'Incan M, Rouanet J, Franck F, Vignon-Pennamen MD, Franck N, Carlotti A, Boulinguez S, Lamant L, Petrella T, Dalac S, Joly P, Courville P, Rivet J, Dereure O, Amatore F, Taix S, Grange F, Durlach A, Quéreux G, Josselin N, Moulonguet I, Mortier L, Dubois R, Maubec E, Laroche L, Michel L, Templier I, Barete S, Nardin C, Augereau O, Vergier B, Bagot M. Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry. Br J Dermatol 2020; 184:1059-1067. [PMID: 33131055 DOI: 10.1111/bjd.19644] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/28/2020] [Indexed: 12/16/2022]
Abstract
BACKGROUND Primary cutaneous lymphomas (PCLs) are a heterogeneous group of T-cell (CTCL) and B-cell (CBCL) malignancies. Little is known about their epidemiology at initial presentation in Europe and about potential changes over time. OBJECTIVES The aim of this retrospective study was to analyse the frequency of PCLs in the French Cutaneous Lymphoma Registry (GFELC) and to describe the demography of patients. METHODS Patients with a centrally validated diagnosis of primary PCL, diagnosed between 2005 and 2019, were included. RESULTS The calculated incidence was unprecedently high at 1·06 per 100 000 person-years. The number of included patients increased yearly. Most PCL subtypes were more frequent in male patients, diagnosed at a median age of 60 years. The relative frequency of rare CTCL remained stable, the proportion of classical mycosis fungoides (MF) decreased, and the frequency of its variants (e.g. folliculotropic MF) increased. Similar patterns were observed for CBCL; for example, the proportion of marginal-zone CBCL increased over time. CONCLUSIONS Changes in PCL frequencies may be explained by the emergence of new diagnostic criteria and better description of the entities in the most recent PCL classification. Moreover, we propose that an algorithm should be developed to confirm the diagnosis of PCL by central validation of the cases.
Collapse
Affiliation(s)
- G Dobos
- Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France
| | - A de Masson
- Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France
| | - C Ram-Wolff
- Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France
| | - M Beylot-Barry
- Dermatology Department, Université de Bordeaux, Bordeaux, France
| | - A Pham-Ledard
- Dermatology Department, Université de Bordeaux, Bordeaux, France
| | - N Ortonne
- Pathology Department, Henri Mondor Hospital, INSERM U955, Université Paris Est, AP-HP, Paris, France
| | - S Ingen-Housz-Oro
- Dermatology Department, Henri Mondor Hospital, INSERM U955, Université Paris Est, AP-HP, Paris, France
| | - M Battistella
- INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France.,Pathology Department, Saint-Louis Hospital, AP-HP, Paris, France
| | - M d'Incan
- Dermatology and Cutaneous Oncology, Estaing University Hospital, Université de Clermont-Ferrand, Clermont-Ferrand, France
| | - J Rouanet
- Pathology Department, NHE Clermont et SIPATH UNILABS, Clermont-Ferrand, France
| | - F Franck
- Pathology Department, NHE Clermont et SIPATH UNILABS, Clermont-Ferrand, France
| | | | - N Franck
- Dermatology Department, Cochin Hospital, AP-HP, Paris, France
| | - A Carlotti
- Pathology Department, Cochin Hospital, AP-HP, Paris, France
| | - S Boulinguez
- Dermatology Department, Cahors Hospital, Toulouse, France
| | - L Lamant
- Pathology and Cytopathology Department, Institut Universitaire du Cancer Toulouse, Toulouse, France
| | - T Petrella
- Pathology Department, Dijon Bourgogne University Hospital, Dijon, France
| | - S Dalac
- Dermatology Department, Dijon Bourgogne University Hospital, Dijon, France
| | - P Joly
- Dermatology Department, Rouen University Hospital, INSERM U1234, Rouen Institute for Research and Innovation in Biomedicine, Rouen, France
| | - P Courville
- Pathology Department, Rouen University Hospital, INSERM U1234, Rouen Institute for Research and Innovation in Biomedicine, Rouen, France
| | - J Rivet
- Dermatology Department, Université de Bordeaux, Bordeaux, France.,Pathology Department, Henri Mondor Hospital, INSERM U955, Université Paris Est, AP-HP, Paris, France
| | - O Dereure
- Dermatology Department, Montpellier University Hospital, Montpellier, France
| | - F Amatore
- Department of Dermatology and Oncodermatology, Aix-Marseille University, AP-HM, Timone Hospital, Marseille, France
| | - S Taix
- Department of Pathology, Aix-Marseille University, AP-HM, Timone Hospital, Marseille, France
| | - F Grange
- Dermatology Department, Robert Debré University Hospital, Reims, France
| | - A Durlach
- Pathology Department, Reims University Hospital, Reims, France
| | - G Quéreux
- Dermatology Department, Nantes University Hospital, Nantes, France
| | - N Josselin
- Pathology Department, Nantes University Hospital, Nantes, France
| | - I Moulonguet
- Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France
| | - L Mortier
- Dermatology Department, Claude Huriez University Hospital, INSERM U1189, Université de Lille, Lille, France
| | - R Dubois
- Pathology Department, Claude Huriez University Hospital, Lille, France
| | - E Maubec
- Dermatology Department, Avicenne Hospital, AP-HP, Paris, France
| | - L Laroche
- Dermatology Department, Avicenne Hospital, AP-HP, Paris, France
| | - L Michel
- INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France
| | - I Templier
- Dermatology Department, Grenoble University Hospital, Grenoble, France
| | - S Barete
- Dermatology Department, Pité-Salpêtrière Hospital, AP-HP, Paris, France
| | - C Nardin
- Dermatology Department, Minjoz Hospital, Besancon, France, INSERM U1098, University of Franche Comté, EFS Bourgogne Franche-Comté and Franche-Comté University, Besançon, France
| | - O Augereau
- Pathology Department, Saint-André Hospital, Bordeaux University Hospital, INSERM U1053 - UMR BaRITOn, Eq 3 Oncogenèse des Lymphomes Cutanés, Université de Bordeaux, Bordeaux, France
| | - B Vergier
- Pathology Department, Saint-André Hospital, Bordeaux University Hospital, INSERM U1053 - UMR BaRITOn, Eq 3 Oncogenèse des Lymphomes Cutanés, Université de Bordeaux, Bordeaux, France
| | - M Bagot
- Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France
| | | |
Collapse
|
13
|
Lamiré LA, Milani P, Runel G, Kiss A, Arias L, Vergier B, de Bossoreille S, Das P, Cluet D, Boudaoud A, Grammont M. Gradient in cytoplasmic pressure in germline cells controls overlying epithelial cell morphogenesis. PLoS Biol 2020; 18:e3000940. [PMID: 33253165 PMCID: PMC7703951 DOI: 10.1371/journal.pbio.3000940] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2019] [Accepted: 10/13/2020] [Indexed: 12/31/2022] Open
Abstract
It is unknown how growth in one tissue impacts morphogenesis in a neighboring tissue. To address this, we used the Drosophila ovarian follicle, in which a cluster of 15 nurse cells and a posteriorly located oocyte are surrounded by a layer of epithelial cells. It is known that as the nurse cells grow, the overlying epithelial cells flatten in a wave that begins in the anterior. Here, we demonstrate that an anterior to posterior gradient of decreasing cytoplasmic pressure is present across the nurse cells and that this gradient acts through TGFβ to control both the triggering and the progression of the wave of epithelial cell flattening. Our data indicate that intrinsic nurse cell growth is important to control proper nurse cell pressure. Finally, we reveal that nurse cell pressure and subsequent TGFβ activity in the stretched cells combine to increase follicle elongation in the anterior, which is crucial for allowing nurse cell growth and pressure control. More generally, our results reveal that during development, inner cytoplasmic pressure in individual cells has an important role in shaping their neighbors.
Collapse
Affiliation(s)
- Laurie-Anne Lamiré
- Laboratoire de Biologie et de Modélisation de la Cellule, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, Lyon, France
| | - Pascale Milani
- Laboratoire de Biologie et de Modélisation de la Cellule, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, Lyon, France
| | - Gaël Runel
- Laboratoire de Biologie et de Modélisation de la Cellule, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, Lyon, France
| | - Annamaria Kiss
- Reproduction et Développement des Plantes, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, INRAE, Lyon, France
| | - Leticia Arias
- Laboratoire de Biologie et de Modélisation de la Cellule, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, Lyon, France
| | - Blandine Vergier
- Laboratoire de Biologie et de Modélisation de la Cellule, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, Lyon, France
| | - Stève de Bossoreille
- Laboratoire de Biologie et de Modélisation de la Cellule, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, Lyon, France
| | - Pradeep Das
- Reproduction et Développement des Plantes, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, INRAE, Lyon, France
| | - David Cluet
- Laboratoire de Biologie et de Modélisation de la Cellule, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, Lyon, France
| | - Arezki Boudaoud
- Reproduction et Développement des Plantes, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, INRAE, Lyon, France
| | - Muriel Grammont
- Laboratoire de Biologie et de Modélisation de la Cellule, Univ Lyon, ENS de Lyon, UCB Lyon 1, CNRS, Lyon, France
| |
Collapse
|
14
|
Cluet D, Amri I, Vergier B, Léault J, Audibert A, Grosjean C, Calabrési D, Spichty M. A Quantitative Tri-fluorescent Yeast Two-hybrid System: From Flow Cytometry to In cellula Affinities. Mol Cell Proteomics 2020; 19:701-715. [PMID: 32015065 PMCID: PMC7124468 DOI: 10.1074/mcp.tir119.001692] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2019] [Revised: 01/31/2020] [Indexed: 12/14/2022] Open
Abstract
We present a technological advancement for the estimation of the affinities of Protein-Protein Interactions (PPIs) in living cells. A novel set of vectors is introduced that enables a quantitative yeast two-hybrid system based on fluorescent fusion proteins. The vectors allow simultaneous quantification of the reaction partners (Bait and Prey) and the reporter at the single-cell level by flow cytometry. We validate the applicability of this system on a small but diverse set of PPIs (eleven protein families from six organisms) with different affinities; the dissociation constants range from 117 pm to 17 μm After only two hours of reaction, expression of the reporter can be detected even for the weakest PPI. Through a simple gating analysis, it is possible to select only cells with identical expression levels of the reaction partners. As a result of this standardization of expression levels, the mean reporter levels directly reflect the affinities of the studied PPIs. With a set of PPIs with known affinities, it is straightforward to construct an affinity ladder that permits rapid classification of PPIs with thus far unknown affinities. Conventional software can be used for this analysis. To permit automated analysis, we provide a graphical user interface for the Python-based FlowCytometryTools package.
Collapse
Affiliation(s)
- David Cluet
- Laboratoire de Biologie et Modé lisation de la Cellule, Ecole Normale Supé rieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364 Lyon cedex 07, France
| | - Ikram Amri
- Laboratoire de Biologie et Modé lisation de la Cellule, Ecole Normale Supé rieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364 Lyon cedex 07, France
| | - Blandine Vergier
- Laboratoire de Biologie et Modé lisation de la Cellule, Ecole Normale Supé rieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364 Lyon cedex 07, France
| | - Jérémie Léault
- Laboratoire de Biologie et Modé lisation de la Cellule, Ecole Normale Supé rieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364 Lyon cedex 07, France
| | - Astrid Audibert
- Laboratoire de Biologie et Modé lisation de la Cellule, Ecole Normale Supé rieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364 Lyon cedex 07, France
| | - Clémence Grosjean
- Laboratoire de Biologie et Modé lisation de la Cellule, Ecole Normale Supé rieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364 Lyon cedex 07, France
| | - Dylan Calabrési
- Laboratoire de Biologie et Modé lisation de la Cellule, Ecole Normale Supé rieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364 Lyon cedex 07, France
| | - Martin Spichty
- Laboratoire de Biologie et Modé lisation de la Cellule, Ecole Normale Supé rieure de Lyon, CNRS, Université Lyon 1, Université de Lyon, 46 allée d'Italie, 69364 Lyon cedex 07, France.
| |
Collapse
|
15
|
Bourlond F, Battistella M, Dousset L, Amici JM, Tuzin N, Vergier B, Beylot-Barry M, Cribier B. Étude clinique de 62 trichoblastomes et comparaison au carcinome basocellulaire nodulaire. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
16
|
Sonigo G, Battistella M, Beylot-Barry M, Oro S, Franck N, Barete S, Boulinguez S, Dereure O, Bonnet N, Socié G, Brice P, Boccara O, Bodemer C, Adamski H, D’Incan M, Ortonne N, Fraitag S, Brunet-Possenti F, Dalle S, Suarez F, Marcais A, Skowron F, Haidar D, Maubec E, Bohelay G, Laroche L, Mahé A, Birckel E, Bouaziz JD, Brocheriou I, Dubois R, Faiz S, Fadlallah J, Ram-Wolff C, Carlotti A, Bens G, Balme B, Vergier B, Laurent-Roussel S, Deschamps L, Carpentier O, Moguelet P, Hervé G, Comoz F, Le Gall F, Leverger G, Finon A, Augereau O, Bléchet C, Kerdraon R, lamant L, Tournier E, Franck F, Costes-Martineau V, Szablewski V, Taix S, Beschet I, Guérin F, Sepulveda F, Bagot M, De Saint-Basile G, Michonneau D, De Masson A. Étude clinique à long terme et mutations HAVCR2 chez 70 patients atteints de lymphome T sous cutané à type de panniculite. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
17
|
Dangien A, Beylot-Barry M, Battistella M, Ram-Wolff C, Talbot A, Rybojad M, Vergier B, Jachiet M, Bouaziz JD, Arnulf B, Bagot M, De Masson A. Association lymphome B cutané primitif de la zone marginale et amyloses cutanées. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
18
|
Amico S, Fouquet C, Rullier A, Lévy M, Vergier B, Fraitag S, Léauté-Labrèze C. Hémangiomatose infantile compliquée de saignements intra-tumoraux. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
19
|
Rimbert J, Battistella M, Migeot V, Cribier B, Vergier B, Frouin E. Faut-il mesurer les marges histologiques d’exérèse des carcinomes basocellulaires ? Enquête des pratiques des pathologistes français. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.078] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
20
|
Dousset L, Boussemart L, Robert C, Mansard S, Lebbe C, Merlio JP, Routier E, Dupuy A, Rouanet J, Battistella M, Capellen D, Galibert MD, Allayous C, Lespagnol A, Villechenoux G, Gerard E, Kerneuzet I, Roy S, Vergier B, Beylot-Barry M. Tumour mutational burden and response to PD-1 inhibitors: An analysis of 89 cases of metastatic melanoma. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz255.043] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
21
|
Dangien A, Beylot‐Barry M, Battistella M, Ram‐Wolff C, Talbot A, Rybojad M, Vergier B, Jachiet M, Bouaziz J, Arnulf B, Bagot M, Masson A. Clinical presentation, therapeutic approach and outcome of primary cutaneous marginal zone B‐cell lymphoma presenting as AL amyloidoma of the skin. Br J Dermatol 2019; 181:607-609. [DOI: 10.1111/bjd.17821] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- A. Dangien
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
| | - M. Beylot‐Barry
- Departments of Dermatology Saint‐André Hospital CHU de Bordeaux INSERM U1053 Université de Bordeaux Bordeaux France
| | - M. Battistella
- Departments of Pathology Saint‐Louis Hospital APHP Paris France
- INSERM U976 Université Paris 7 Paris France
| | - C. Ram‐Wolff
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
| | - A. Talbot
- Departments of Immuno‐hematology Saint‐Louis Hospital APHP Paris France
| | - M. Rybojad
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
| | - B. Vergier
- Departments of Pathology Saint‐André Hospital CHU de Bordeaux INSERM U1053 Université de Bordeaux Bordeaux France
| | - M. Jachiet
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
| | - J.‐D. Bouaziz
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
- INSERM U976 Université Paris 7 Paris France
| | - B. Arnulf
- Departments of Immuno‐hematology Saint‐Louis Hospital APHP Paris France
| | - M. Bagot
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
- INSERM U976 Université Paris 7 Paris France
| | - A. Masson
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
- INSERM U976 Université Paris 7 Paris France
| |
Collapse
|
22
|
Legrand A, Pham-Ledard A, Vergier B, Merlio JP, Beylot-Barry M. Primary cutaneous marginal zone lymphoma: relevance of searching for a blood B-cell clone? Eur J Cancer 2019. [DOI: 10.1016/s0959-8049(19)30546-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
23
|
Castagna J, Parrens M, Nardin C, Angonin R, Bedgedjian I, Vergier B, Merlio J, Aubin F, Beylot-Barry M. Primary cutaneous peripheral T-cell lymphoma not otherwise specified: a comparative clinicopathological analysis of 5 cases. Eur J Cancer 2019. [DOI: 10.1016/s0959-8049(19)30576-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
24
|
Gerard E, Dupuis F, Lamant L, Torossian N, Chaltiel L, Filleron T, Beylot-Barry M, Dutriaux C, Prey S, Gros A, Jullie ML, Meyer N, Vergier B. Évaluation des critères cliniques, pathologiques et moléculaires prédictifs de réponse à l’immunothérapie anti-PD1 dans le mélanome métastatique : analyse rétrospective de 70 patients. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
25
|
Ducharme O, Beylot-Barry M, Pham-Ledard A, Laharanne E, Faur N, Prochazkova-Carlotti M, Vergier B, Merlio JP, Gros A. Identification de marqueurs de réponse au rituximab-polychimiothérapie des lymphomes B cutanés primitifs diffus à grandes cellules de type jambe par analyse protéomique et mutationnelle. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
26
|
Maridet C, Morice-Picard F, Gros A, Crivelli L, de la Fouchardière A, Vergier B, Taïeb A. Mosaic NRASopathy in a child with giant melanocytic congenital naevus, epidermal hamartoma and bilateral nephroblastomatosis: clinical implication for follow-up. J Eur Acad Dermatol Venereol 2018; 32:e258-e260. [DOI: 10.1111/jdv.14780] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- C. Maridet
- Department of Dermatology and Pediatric Dermatology; National Reference Centre for Rare Disorders; Hôpital des enfants Pellegrin; Centre Hospitalier Universitaire du Bordeaux, place Amélie Raba Léon; Bordeaux 33000 France
| | - F. Morice-Picard
- Department of Dermatology and Pediatric Dermatology; National Reference Centre for Rare Disorders; Hôpital des enfants Pellegrin; Centre Hospitalier Universitaire du Bordeaux, place Amélie Raba Léon; Bordeaux 33000 France
| | - A. Gros
- Tumor Bank and Tumor Biology Laboratory; CHU de Bordeaux; Hôpital Haut-Lévêque, Avenue De Magellan, 33600 Pessac France
| | - L. Crivelli
- Tumor Bank and Tumor Biology Laboratory; CHU de Bordeaux; Hôpital Haut-Lévêque, Avenue De Magellan, 33600 Pessac France
| | | | - B. Vergier
- Department of Pathology; CHU de Bordeaux; Pessac France
| | - A. Taïeb
- Department of Dermatology and Pediatric Dermatology; National Reference Centre for Rare Disorders; Hôpital des enfants Pellegrin; Centre Hospitalier Universitaire du Bordeaux, place Amélie Raba Léon; Bordeaux 33000 France
| |
Collapse
|
27
|
Visseaux L, Durlach A, Barete S, Beylot-Barry M, Bonnet N, Chassine A, Franck N, Herve G, Leclec'h C, Machet L, Ingen-Housz-Oro S, Petrella T, Vergier B, Ortonne N, Grange F. T-cell papulosis associated with B-cell malignancy: a distinctive clinicopathologic entity. J Eur Acad Dermatol Venereol 2018; 32:1469-1475. [DOI: 10.1111/jdv.14805] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Accepted: 01/03/2018] [Indexed: 10/18/2022]
Affiliation(s)
- L. Visseaux
- Service de Dermatologie; Hôpital Robert Debré; Reims France
| | - A. Durlach
- Laboratoire Pol Bouin; Hôpital Maison Blanche; Reims France
| | - S. Barete
- Service de Dermatologie; Hôpital Pitié-Salpêtrière; Paris France
| | - M. Beylot-Barry
- Service de Dermatologie; Hôpital Saint-André; Bordeaux France
| | - N. Bonnet
- Dermatologie; Institut Paoli Calmettes; Marseille France
| | | | - N. Franck
- Service de Dermatologie; Hôpital Cochin; Paris France
| | - G. Herve
- Service de Pathologie; Hôpital Pitié-Salpêtrière; Paris France
| | - C. Leclec'h
- Service de Dermatologie; CHU d'Angers; Angers France
| | - L. Machet
- Service de Dermatologie; Hôpital Trousseau; Tours France
| | | | - T. Petrella
- Department of Hematology-Oncology; University of Montréal; Montréal Canada
| | - B. Vergier
- Service de Pathologie; Hôpital Haut-Levêque; Pessac France
| | - N. Ortonne
- Service de Pathologie; Hôpital Henri Mondor; Créteil France
| | - F. Grange
- Service de Dermatologie; Hôpital Robert Debré; Reims France
| |
Collapse
|
28
|
Ducharme O, Pham-Ledard A, Darrigade AS, Cazorla C, Duffau P, Vergier B, Beylot-Barry M. Lymphome T à type de panniculite α/β : un lymphome pas toujours de bon pronostic. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
29
|
Marti A, Furudoï A, Vergier B, Beylot-Barry M, Cribier B, Coindre JM, Cogrel O. Dermatomyofibrome cervical géant : à propos de deux cas. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
30
|
Beylot-Barry M, Bregeon B, Jullie ML, Vergier B, Bagot M. Lymphome cutané anaplasique T CD30+ muqueux : rangez les bistouris ! Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
31
|
Daguze J, Saint-Jean M, Quereux G, Peuvrel L, Muguet-Guenot L, Josselin N, Vergier B, Dréno B. Combinaison propranolol et cyclophosphamide dans l’angiosarcome : à propos de deux cas. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
32
|
Dousset L, Amici JM, Cribier B, Battistella M, Vergier B, Bailly JY, Cogrel O, Alfaro C, Ezzedine K, Beylot-Barry M. Étude prospective multicentrique de 2710 carcinomes basocellulaires : concordance entre agressivité clinique supposée et agressivité histologique. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.145] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
33
|
Lamoureux A, Vergier B, Fidelin-Ferrati G, Hans P, Milpied N, Beylot-Barry M. « Malignant » Rosacea as a sign of systemic marginal zone lymphoma. J Eur Acad Dermatol Venereol 2017; 32:e71-e72. [PMID: 28776782 DOI: 10.1111/jdv.14502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- A Lamoureux
- Dermatology Department, CHU Bordeaux, Bordeaux, France
| | - B Vergier
- INSERM U1053, Bordeaux Research in Translational Oncology, Team 3 Oncogenesis of Cutaneous Lymphomas, University of Bordeaux, Bordeaux, France.,Pathology Department, CHU Bordeaux, Pessac, France
| | | | - P Hans
- Dermatology Practice, Mont de Marsan, France
| | - N Milpied
- Hematology Department, CHU Bordeaux, Pessac, France
| | - M Beylot-Barry
- Dermatology Department, CHU Bordeaux, Bordeaux, France.,INSERM U1053, Bordeaux Research in Translational Oncology, Team 3 Oncogenesis of Cutaneous Lymphomas, University of Bordeaux, Bordeaux, France
| |
Collapse
|
34
|
Jardin F, Mareschal S, Pham-Ledard A, Viailly P, Carlotti M, Dubois S, Bertrand P, Maingonnat C, Bohers E, Ruminy P, Tournier I, Courville P, Duval A, Andrieu E, Verneuil L, Fontanillles M, Vergier B, Tilly H, Joly P, Frebourg T, Beylot-Barry M, Merlio J. THE LANDSCAPE OF SOMATIC MUTATIONS OF PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA, LEG-TYPE. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_97] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- F. Jardin
- Hematology; Henri Becquerel Center; Rouen France
| | - S. Mareschal
- Team Genetics and Biomarkers in Lymphoma and Solid Tumors, INSERM U1245; Rouen France
| | - A. Pham-Ledard
- Inserm U1053, Team “Oncogenesis of Cutaneous Lymphoma”, CHU Bordeaux; Bordeaux France
| | - P. Viailly
- Team Genetics and Biomarkers in Lymphoma and Solid Tumors, INSERM U1245; Rouen France
| | - M. Carlotti
- Inserm U1053, Team “Oncogenesis of Cutaneous Lymphoma”, CHU Bordeaux; Bordeaux France
| | - S. Dubois
- Team Genetics and Biomarkers in Lymphoma and Solid Tumors, INSERM U1245; Rouen France
| | - P. Bertrand
- Team Genetics and Biomarkers in Lymphoma and Solid Tumors, INSERM U1245; Rouen France
| | - C. Maingonnat
- Team Genetics and Biomarkers in Lymphoma and Solid Tumors, INSERM U1245; Rouen France
| | - E. Bohers
- Team Genetics and Biomarkers in Lymphoma and Solid Tumors, INSERM U1245; Rouen France
| | - P. Ruminy
- Team Genetics and Biomarkers in Lymphoma and Solid Tumors, INSERM U1245; Rouen France
| | - I. Tournier
- Department of Genetics, Normandie Univ, UNIROUEN; Inserm U1245 and Rouen University Hospital; Rouen France
| | - P. Courville
- Departments of Dermatology and Pathology; Rouen University Hospital; Rouen France
| | - A. Duval
- Departments of Dermatology and Pathology; Rouen University Hospital; Rouen France
| | - E. Andrieu
- Departments of Dermatology and Pathology; Rouen University Hospital; Rouen France
| | - L. Verneuil
- Departments of Dermatology and Pathology, Caen CHU; Caen France
| | - M. Fontanillles
- Team Genetics and Biomarkers in Lymphoma and Solid Tumors, INSERM U1245; Rouen France
| | - B. Vergier
- Inserm U1053, Team “Oncogenesis of Cutaneous Lymphoma”, CHU Bordeaux; Bordeaux France
| | - H. Tilly
- Team Genetics and Biomarkers in Lymphoma and Solid Tumors, INSERM U1245; Rouen France
| | - P. Joly
- Departments of Dermatology and Pathology; Rouen University Hospital; Rouen France
| | - T. Frebourg
- Department of Genetics, Normandie Univ, UNIROUEN; Inserm U1245 and Rouen University Hospital; Rouen France
| | - M. Beylot-Barry
- Inserm U1053, Team “Oncogenesis of Cutaneous Lymphoma”, CHU Bordeaux; Bordeaux France
| | - J. Merlio
- Inserm U1053, Team “Oncogenesis of Cutaneous Lymphoma”, CHU Bordeaux; Bordeaux France
| |
Collapse
|
35
|
Fougerouse A, Dutkiewicz AS, Pillet P, Vergier B, Boralevi F, Leaute-Labreze C. PAN de l’enfant : chercher le syndrome auto-inflammatoire. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
36
|
Visseaux L, Durlach A, Barete S, Bayaram M, Beylot-Barry M, Bonnet N, Chassine A, Combemale P, Dhaille F, Franck N, Hervé G, Leclec’h C, Machet L, Oro S, Petrella T, Vergier B, Ortonne N, Grange F. Papulose T associée aux hémopathies B. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
37
|
Eyraud A, Pham-Ledard A, Fiore M, Beylot-Barry M, Vergier B. Maladie de Willebrand : un syndrome paranéoplasique ? Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
38
|
Mermin D, Bonnet N, Bouabdallah R, Duval-Modeste AB, Mortier L, Oro S, Ram-Wolff C, Barete S, Dalle S, Maubec E, Quereux G, Templier I, Bagot M, Grange F, Vergier B, Merlio JP, Pham-Ledard A, Dousseau A, Maillard A, Beylot-Barry M. Lenalidomide dans les lymphomes cutanés primitifs B diffus à grandes cellules type-jambe en rechute ou réfractaires : PHRC REV-LEG. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
39
|
Lamoureux A, Vergier B, Fidelin-Ferrati G, Hans P, Milpied N, Beylot-Barry M. Des rosacées « malignes » : une présentation parfois révélatrice de lymphoprolifération B à petites cellules. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
40
|
Campana F, Carvelli J, Fricain JC, Vergier B, Boralevi F, Kaplanski G. [Reached multifocal secondary syphilis: A case presentation]. ACTA ACUST UNITED AC 2016; 117:104-7. [PMID: 26964840 DOI: 10.1016/j.revsto.2016.01.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2015] [Revised: 11/27/2015] [Accepted: 01/22/2016] [Indexed: 11/28/2022]
Abstract
INTRODUCTION Syphilis is a sexually transmitted infection (STI) related to Treponema pallidum. Secondary syphilis is the blood-borne systemic spread of Treponema. OBSERVATION We report the case of secondary syphilis in a patient without risk of STIs factor. The clinical picture began with a genital affection followed by oral erosions and ulcers and an anterior and then posterior uveitis. Serology established the diagnosis and intravenous penicillin G treatment allowed for healing. DISCUSSION Called the "great pretender" because of its clinical polymorphism, secondary syphilis can lead to formidable neurological and ophthalmological complications. Serological diagnosis is based on the use of treponemal and a nontreponemal tests. Penicillin G remains the treatment of choice and must be adapted according to the clinical damage.
Collapse
Affiliation(s)
- F Campana
- Centre Massilien de la face, 24, avenue du Prado, 13006 Marseille, France.
| | - J Carvelli
- Service de médecine interne, Assistance publique-Hôpitaux de Marseille, hôpital de la Conception, 13005 Marseille, France
| | - J C Fricain
- Service d'odontologie, CHU de Bordeaux, hôpital Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux, France
| | - B Vergier
- Service d'anatomopathologie, CHU de Bordeaux, avenue de Magellan, 33604 Bordeaux cedex, France
| | - F Boralevi
- Service de dermatologie, CHU de Bordeaux, hôpital Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux, France
| | - G Kaplanski
- Service de médecine interne, Assistance publique-Hôpitaux de Marseille, hôpital de la Conception, 13005 Marseille, France
| |
Collapse
|
41
|
Gérard E, Ly S, Cogrel O, Pham-Ledard A, Fauconneau A, Penchet I, Ouhabrache N, Vergier B, Beylot-Barry M. [Primary localized cutaneous nodular amyloidosis: A diagnostic and therapeutic challenge]. Ann Dermatol Venereol 2015; 143:134-8. [PMID: 26724842 DOI: 10.1016/j.annder.2015.10.596] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2015] [Revised: 10/12/2015] [Accepted: 10/29/2015] [Indexed: 11/17/2022]
Abstract
BACKGROUND Nodular primary localized cutaneous amyloidosis (PLCA) is a rare subtype of localized cutaneous amyloidosis in which amyloid protein is derived from immunoglobulin light chains. Follow-up for progression to systemic amyloidosis or autoimmune disease is mandatory. No consensus exists regarding treatment. PATIENTS AND METHODS We report a case of nodular PLCA in a 49-year-old man, presenting as an asymptomatic nodule of the nose. Skin biopsy revealed diffuse deposition of amyloid associated with plasmocyte proliferation. Monotypic kappa light-chain restriction was observed. Extensive systemic evaluation, including bone marrow biopsy and PET scan, was negative. Protein electrophoresis and immunofixation in serum and urine were normal. The nodule was treated with radiotherapy but there was no response. Mohs micrographic surgery (MMS) was performed with no recurrence at 6 months of follow-up. No systemic progression was observed one year after the initial diagnosis. DISCUSSION Since nodular PLCA may have a cutaneous presentation similar to that of primary systemic amyloidosis, evaluation for systemic amyloidosis is necessary. Treatment of amyloidosis is difficult. Radiotherapy appears ineffective in treating this type of primary cutaneous amyloidosis, and surgical treatment, where possible, is a good option, especially with MMS, which allows both controlled excision and minimal margins.
Collapse
Affiliation(s)
- E Gérard
- Service de dermatologie, hôpital Saint-André, CHU de Bordeaux, rue Jean-Burguet, 33076 Bordeaux, France
| | - S Ly
- Service de dermatologie, hôpital Saint-André, CHU de Bordeaux, rue Jean-Burguet, 33076 Bordeaux, France
| | - O Cogrel
- Service de dermatologie, hôpital Saint-André, CHU de Bordeaux, rue Jean-Burguet, 33076 Bordeaux, France
| | - A Pham-Ledard
- Service de dermatologie, hôpital Saint-André, CHU de Bordeaux, rue Jean-Burguet, 33076 Bordeaux, France
| | - A Fauconneau
- Service de dermatologie, hôpital Saint-André, CHU de Bordeaux, rue Jean-Burguet, 33076 Bordeaux, France
| | - I Penchet
- Service d'anatomopathologie, hôpital Haut-Lévêque, CHU de Bordeaux, avenue de Magellan, 33604 Pessac, France
| | - N Ouhabrache
- Service de radiothérapie, hôpital Haut-Lévêque, CHU de Bordeaux, avenue de Magellan, 33604 Pessac, France
| | - B Vergier
- Service d'anatomopathologie, hôpital Haut-Lévêque, CHU de Bordeaux, avenue de Magellan, 33604 Pessac, France
| | - M Beylot-Barry
- Service de dermatologie, hôpital Saint-André, CHU de Bordeaux, rue Jean-Burguet, 33076 Bordeaux, France.
| |
Collapse
|
42
|
Leclaire Alirkilicarslan A, Dupuy A, Pujals A, Parrens M, Vergier B, Delfau MH, Oro S, Haioun C, Beylot-Barry M, Merlio JP, Gaulard P, Ortonne N. Caractérisation morphologique, phénotypique et moléculaire des infiltrats cutanés survenant au cours du lymphome T angio-immunoblastique : mise en évidence de la mutation RHOA p.G17V in situ. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
43
|
Gerard E, Guillot P, Cogrel O, Doutre MS, Beylot-Barry M, Vergier B. Critères de transformation du dermatofibrosarcome de Darier-Ferrand : implications thérapeutique et pronostique. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
44
|
Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, Picardo M, Taieb A, Ezzedine K, Cario-André M. Inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br J Dermatol 2015; 170:816-23. [PMID: 24734946 DOI: 10.1111/bjd.12691] [Citation(s) in RCA: 54] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/14/2013] [Indexed: 12/13/2022]
Abstract
BACKGROUND Polymorphisms of NLR (nucleotide-binding domain and leucine rich repeat containing) family, pyrin domain containing protein 1 (NLRP1) have been found in patients with vitiligo/nonsegmental vitiligo (NSV), and increased NLRP1 expression has been detected in the leading edge of lesional skin biopsies. OBJECTIVES To evaluate the presence and intensity of NLRP1 immunostaining in lesional and perilesional skin of patients with vitiligo/NSV and to search for possible correlations between NLRP1 and interleukin (IL)-1β expression, lymphocytic infiltrates and disease activity. METHODS Of 14 consecutive vitiligo/NSV patients, eight had active disease [Vitiligo European Task Force (VETF) spreading score +1 to +5], one patient had stable disease and five patients had regressive disease (VETF spreading score -1 to -3). We performed immunostaining for NLRP1, B and T lymphocytes, IL-1β and kallikrein 7 on lesional and perilesional vitiligo skin. RESULTS NLRP1 and IL-1β immunostaining in perilesional vitiligo/NSV skin was significantly associated with progressive disease (P = 0·009 and 0·04, respectively) and performed better than the simple detection of lymphocytic infiltrates. CONCLUSIONS Our findings suggest that markers of the NLRP1 inflammasome could be a useful test for assessing disease activity in addition to the detection of inflammatory infiltrates in the progressing margins of vitiligo/NSV lesions.
Collapse
Affiliation(s)
- J Marie
- National Reference Centre for Rare Skin Diseases, Hôpital St André, CHU de Bordeaux, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Fauconneau A, Pham-Ledard A, Cappellen D, Frison E, Prochazkova-Carlotti M, Parrens M, Dalle S, Joly P, Viraben R, Franck F, Ingen-Housz-Oro S, Giacchero D, Jullié ML, Vergier B, Merlio JP, Beylot-Barry M. Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases. Br J Dermatol 2015; 172:1547-1554. [DOI: 10.1111/bjd.13690] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/18/2015] [Indexed: 11/30/2022]
Affiliation(s)
- A. Fauconneau
- Department of Dermatology; Hôpital Haut Lévêque; Avenue de Magellan; 33604 PESSAC France
| | - A. Pham-Ledard
- Department of Dermatology; Hôpital Haut Lévêque; Avenue de Magellan; 33604 PESSAC France
- EA2406 Histology and Molecular Pathology of Tumors; Université de Bordeaux; Bordeaux France
| | - D. Cappellen
- EA2406 Histology and Molecular Pathology of Tumors; Université de Bordeaux; Bordeaux France
| | - E. Frison
- Pole de Sante Publique; Service d'information Médicale; CHU Bordeaux; Bordeaux France
| | | | - M. Parrens
- EA2406 Histology and Molecular Pathology of Tumors; Université de Bordeaux; Bordeaux France
- Department of Pathology; CHU Bordeaux; Bordeaux France
| | - S. Dalle
- Centre de Recherche en Cancérologie de Lyon; Université Claude Bernard Lyon 1; Hospices Civils de Lyon; Lyon France
| | - P. Joly
- Department of Dermatology; CHU Rouen; Rouen France
| | - R. Viraben
- Department of Dermatology; CHU Toulouse; Toulouse France
| | - F. Franck
- Department of Pathology; CHU Clermont-Ferrand; Université d'Auvergne; Clermont-Ferrand France
| | | | - D. Giacchero
- Department of Dermatology; CHU Nice; Nice France
| | - M.-L. Jullié
- Department of Pathology; CHU Bordeaux; Bordeaux France
| | - B. Vergier
- EA2406 Histology and Molecular Pathology of Tumors; Université de Bordeaux; Bordeaux France
- Department of Pathology; CHU Bordeaux; Bordeaux France
| | - J.-P. Merlio
- EA2406 Histology and Molecular Pathology of Tumors; Université de Bordeaux; Bordeaux France
- Tumor Bank and Department of Tumor Biology; CHU Bordeaux; Bordeaux France
| | - M. Beylot-Barry
- Department of Dermatology; Hôpital Haut Lévêque; Avenue de Magellan; 33604 PESSAC France
- EA2406 Histology and Molecular Pathology of Tumors; Université de Bordeaux; Bordeaux France
| |
Collapse
|
46
|
Védie AL, Fauconneau A, Vergier B, Imbert E, de la Valussière G, Demay O, Larrouy-Midy C, Doutre MS. Macular lymphocytic arteritis, a new cutaneous vasculitis. J Eur Acad Dermatol Venereol 2015; 30:542-4. [DOI: 10.1111/jdv.12941] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- A.-L. Védie
- Service de dermatologie; Hôpital Haut-Lévêque; Chu Bordeaux; Avenue de Magellan Pessac 33604 France
| | - A. Fauconneau
- Service de dermatologie; Hôpital Haut-Lévêque; Chu Bordeaux; Avenue de Magellan Pessac 33604 France
| | - B. Vergier
- Service d'anatomie et cytologie pathologique; Hôpital Haut-Lévêque; Chu Bordeaux; Avenue de Magellan Pessac 33604 France
| | - E. Imbert
- Service de dermatologie; Hôpital Haut-Lévêque; Chu Bordeaux; Avenue de Magellan Pessac 33604 France
| | - G. de la Valussière
- Service de dermatologie; Hôpital Haut-Lévêque; Chu Bordeaux; Avenue de Magellan Pessac 33604 France
| | - O. Demay
- Service de dermatologie; Hôpital Haut-Lévêque; Chu Bordeaux; Avenue de Magellan Pessac 33604 France
| | - C. Larrouy-Midy
- Service de dermatologie; Hôpital Haut-Lévêque; Chu Bordeaux; Avenue de Magellan Pessac 33604 France
| | - M.-S. Doutre
- Service de dermatologie; Hôpital Haut-Lévêque; Chu Bordeaux; Avenue de Magellan Pessac 33604 France
| |
Collapse
|
47
|
Dutkiewicz AS, Beylot-Barry M, Vergier B. Dermatite interstitielle granulomateuse : réelle entité ? Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
48
|
Pham-Ledard A, Beylot-Barry M, Barbe C, Leduc M, Petrella T, Vergier B, Martinez F, Cappellen D, Merlio JP, Grange F. La mutation MYD88 L265P est fréquente et a une valeur pronostique péjorative dans les lymphomes cutanés B diffus à grandes cellules de type jambe. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
49
|
Gerard E, Taieb A, Vergier B. Une fausse dermatose dévotionnelle chez un patient d’origine pakistanaise. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
50
|
Bertolotti A, Pham-Ledard A, Petrot D, Coindre MC, Brecheteau P, Mendes I, Vergier B, Beylot-Barry M. [Two cases of proliferation of monoclonal and monotypic lymphocytes and plasma cells corresponding to acrodermatitis chronica atrophicans]. Ann Dermatol Venereol 2014; 141:452-7. [PMID: 24951145 DOI: 10.1016/j.annder.2014.04.117] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2013] [Revised: 03/02/2014] [Accepted: 04/02/2014] [Indexed: 11/25/2022]
Abstract
BACKGROUND While a dermal proliferation of monotypic monoclonal lymphocytes and plasma cells suggests above all cutaneous marginal zone lymphoma (CMZL) or plasmacytoma, it may also correspond to a Borrelia infection of which the clinic picture is evocative, as demonstrated in the cases presented herein. PATIENTS AND METHODS The files of two patients were submitted for discussion at the regional multidisciplinary staff meeting on cutaneous lymphomas after review of the skin biopsies led to a diagnosis of plasmacytoma and CMZL on the basis of infiltrate containing abundant plasma cells. The infiltrates of both patients showed a kappa monotypic light chain and cutaneous B-cell clones were detected. However, the clinical features, with monomelic maculopapular rash, were evocative primarily of Borrelia infection. Diagnosis was confirmed by positive serology and clinical cure was achieved after 3 weeks of oral tetracycline, without relapse. COMMENTS A link between Borrelia infection and cutaneous lymphomas has long been thought to exist. Further, it is recommended that antibiotics be considered in CMZL before undertaking systemic therapy. The classic histological appearance of the tertiary phase of early-stage Lyme's disease shows perivascular and periadnexal infiltrate comprising lymphocytes and plasma cells. At the later stages, epidermal atrophy occurs with thinning of the dermis. The monoclonal and monotypic nature of skin proliferation points above all to CMZL or plasmacytoma. However, clinicopathological correlation is an essential step before such a diagnosis may be made. In the event of monomelic erythema, as in our patients, it is important to screen for Borrelia infection, which responds well to appropriate treatment.
Collapse
Affiliation(s)
- A Bertolotti
- Service de dermatologie, hôpital Haut-Lévêque, CHU de Bordeaux, université de Bordeaux, avenue de Magellan, 33604 Pessac, France
| | - A Pham-Ledard
- Service de dermatologie, hôpital Haut-Lévêque, CHU de Bordeaux, université de Bordeaux, avenue de Magellan, 33604 Pessac, France
| | - D Petrot
- Centre de pathologie, 158-160, boulevard Émile-Delmas, BP 52049, 17000 La Rochelle, France
| | - M-C Coindre
- Cabinet de dermatologie, 14, avenue de Limoges, 79000 Niort, France
| | - P Brecheteau
- Dermatologie, hôpital Layné, avenue Pierre-de-Coubertin, 40000 Mont-de-Marsan, France
| | - I Mendes
- Cabinet de pathologie, 28-32, rue Thore, 40100 Dax, France
| | - B Vergier
- Service d'anatomie et de cytologie pathologiques, hôpital Haut-Lévêque, CHU de Bordeaux, université de Bordeaux, avenue de Magellan, 33604 Pessac, France
| | - M Beylot-Barry
- Service de dermatologie, hôpital Haut-Lévêque, CHU de Bordeaux, université de Bordeaux, avenue de Magellan, 33604 Pessac, France.
| |
Collapse
|